These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20530040)

  • 21. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
    Bernasconi M; Tamm M; Bingisser R; Miedinger D; Leuppi J; Müller B; Christ-Crain M; Stolz D
    Chest; 2011 Jul; 140(1):91-99. PubMed ID: 21106656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia.
    Ramirez P; Garcia MA; Ferrer M; Aznar J; Valencia M; Sahuquillo JM; Menéndez R; Asenjo MA; Torres A
    Eur Respir J; 2008 Feb; 31(2):356-62. PubMed ID: 17959634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
    Katan M; Fluri F; Schuetz P; Morgenthaler NG; Zweifel C; Bingisser R; Kappos L; Steck A; Engelter ST; Müller B; Christ-Crain M
    J Am Coll Cardiol; 2010 Sep; 56(13):1045-53. PubMed ID: 20846604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
    Vazquez M; Jockers K; Christ-Crain M; Zimmerli W; Müller B; Schuetz P
    Int J Cardiol; 2012 Apr; 156(1):16-23. PubMed ID: 21093937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The application value of the procalcitonin clearance rate on therapeutic effect and prognosis of ventilator associated pneumonia].
    Abula A; Wang Y; Ma L; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):780-4. PubMed ID: 25399890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
    Meune C; Twerenbold R; Drexler B; Balmelli C; Wolf C; Haaf P; Reichlin T; Irfan A; Reiter M; Zellweger C; Meissner J; Stelzig C; Freese M; Capodarve I; Mueller C
    Am J Cardiol; 2012 Apr; 109(8):1117-23. PubMed ID: 22257708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1.
    Guignant C; Venet F; Voirin N; Poitevin F; Malcus C; Bohé J; Lepape A; Monneret G
    Clin Chem Lab Med; 2010 Dec; 48(12):1813-20. PubMed ID: 20704539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of ventilator-associated pneumonia: a pilot, exploratory analysis of a new score based on procalcitonin and chest echography.
    Zagli G; Cozzolino M; Terreni A; Biagioli T; Caldini AL; Peris A
    Chest; 2014 Dec; 146(6):1578-1585. PubMed ID: 25144666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Sequential Organ Failure Assessment score and copeptin for predicting survival in ventilator-associated pneumonia.
    Boeck L; Eggimann P; Smyrnios N; Pargger H; Thakkar N; Siegemund M; Morgenthaler NG; Rakic J; Tamm M; Stolz D
    J Crit Care; 2012 Oct; 27(5):523.e1-9. PubMed ID: 21958973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia.
    Seligman R; Meisner M; Lisboa TC; Hertz FT; Filippin TB; Fachel JM; Teixeira PJ
    Crit Care; 2006; 10(5):R125. PubMed ID: 16956405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
    von Haehling S; Papassotiriou J; Hartmann O; Doehner W; Stellos K; Geisler T; Wurster T; Schuster A; Botnar RM; Gawaz M; Bigalke B
    Clin Sci (Lond); 2012 Nov; 123(10):601-10. PubMed ID: 22690794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of leptin serum level in diagnosing ventilator-associated pneumonia: a case-control study.
    Parmentier-Decrucq E; Nseir S; Makris D; Desrousseaux B; Soudan B; Favory R; Mathieu D
    Minerva Anestesiol; 2014 Jan; 80(1):39-47. PubMed ID: 24107832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
    Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic value of procalcitonin in ventilator associated pneumonia].
    Zhou CD; Lu ZY; Ren NZ; Zhang GC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Jun; 18(6):370-2. PubMed ID: 16784569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
    Katan M; Moon Y; von Eckardstein A; Spanaus K; DeRosa J; Gutierrez J; DeCarli C; Wright C; Sacco R; Elkind M
    Stroke; 2017 Mar; 48(3):604-610. PubMed ID: 28123058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
    Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
    Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of procalcitonin in the diagnosis of ventilator-associated pneumonia].
    Liao XL; Jin XD; Kang Y; Deng YY; Zhang ZW; Zhou Y; Zhang ZW; Liu C; Yin WH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Mar; 22(3):142-5. PubMed ID: 20367902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia.
    Esposito S; Di Gangi M; Cardinale F; Baraldi E; Corsini I; Da Dalt L; Tovo PA; Correra A; Villani A; Sacco O; Tenero L; Dones P; Gambino M; Zampiero A; Principi N;
    PLoS One; 2016; 11(11):e0163262. PubMed ID: 27846213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.